Pembrolizumab plus Chemotherapy for Pleural Mesothelioma

The addition of pembrolizumab to platinum-based chemotherapy improved overall survival compared with chemotherapy alone in patients with advanced pleural mesothelioma.

Saved in:
Bibliographic Details
Published inNEJM journal watch. Oncology & hematology
Main Author Patel, Jyoti D
Format Journal Article
LanguageEnglish
Published Waltham Massachusetts Medical Society 20.11.2023
Subjects
Chemotherapy
Histology
Immunotherapy
Mesothelioma
Online AccessGet full text

Cover

More Information
Summary:The addition of pembrolizumab to platinum-based chemotherapy improved overall survival compared with chemotherapy alone in patients with advanced pleural mesothelioma.
ISSN:2330-0426